The Efficacy of Bisphosphonates in Preventing Aromatase Inhibitor Induced Bone Loss for Postmenopausal Women with Early Breast Cancer: A Systematic Review and Meta-Analysis
Figure 2
(a) Forest plot from the meta-analysis of LS BMD score analysis of patients at 12 months, who had normal BMD at baseline, between immediate and delayed zoledronic acid groups. (b) Funnel plot from the meta-analysis of LS BMD score analysis of patients at 12 months, who had normal BMD at baseline, between immediate and delayed zoledronic acid groups.
